Clinical trial
Perioperative Recombinant Human Brain Natriuretic Peptide for Renal Protection in Cardiac Surgery: the PROTECT-CS Randomized Clinical Trial
NCT07617675 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Recombinant Human Brain Natriuretic Peptide for Renal Protection in Cardiac Surgery: the PROTECT-CS Randomized Clinical Trial
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- July 31, 2029
- Enrollment
- 694 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aki - acute kidney injury, cardiac surgical procedures, cardiopulmonary bypass